呼气峰流速波动分析与哮喘治疗失败的相关性
本研究对LOCCS试验中493名哮喘患者每日呼气峰流速(PEF)数据进行去趋势波动分析,评估PEF变异系数(CVpef)和标度指数α与治疗失败的关系。结果显示治疗失败者CVpef更高,治疗期F和F+S组α更高,但α变化模式个体差异大。提示PEF波动自相似性增加与治疗失败相关。
要点
- PEF变异系数(CVpef)升高与哮喘治疗失败相关。
- 治疗期标度指数α在F和F+S组治疗失败者中更高。
- α变化模式个体差异大,需个体化解读。
核心结论
- 肺功能波动性增加(CVpef升高)且时间自相似性(α)增加与哮喘治疗失败相关。
- 治疗失败前α的变化模式存在个体差异。
研究设计与样本
- 对LOCCS试验中493名参与者每日一次PEF数据进行去趋势波动分析。
- 评估CVpef和标度指数α与治疗失败的关系。
主要发现
- 在F和F+S组治疗失败者中,CVpef在导入期和干预期均更高。
- 治疗期F和F+S组治疗失败者α更高。
- 所有三组治疗失败前α变化模式不一。
临床怎么用
- 可考虑将PEF波动分析用于哮喘治疗失败的预测评估。
- 需注意α变化模式个体差异,不宜统一解读。
局限性
- 研究基于LOCCS试验数据,结论外推需谨慎。
- α变化模式个体差异大,预测价值受限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE: Temporal fluctuations have been demonstrated in lung function and asthma control, but the effect of controller therapy on these fluctuations is unknown. OBJECTIVES: To determine if fluctuations in peak expiratory flow (PEF) are predictive of subsequent treatment failure and may be modified by controller therapy. METHODS: We applied detrended fluctuation analysis to once-daily PEF data from 493 participants in the LOCCS (Leukotriene Modifier Corticosteroid or Corticosteroid-Salmeterol) trial of the American Lung Association Airways Clinical Research Centers. We evaluated the coefficient of variation of PEF (CVpef) and the scaling exponent α, reflecting self-similarity of PEF, in relation to treatment failure from the run-in period of open-label inhaled fluticasone, and the treatment periods for subjects randomized to (1) continued twice daily fluticasone (F), (2) once daily fluticasone plus salmeterol (F + S), or (3) once daily oral montelukast (M). MEASUREMENTS AND MAIN RESULTS: The CVpef was higher in those with treatment failure in the F and F + S groups in the run-in phase, and all three groups in the treatment phase. α was similar between those with and without treatment failure in all three groups during the run-in phase but was higher among those with treatment failure in the F and F + S groups during the treatment phase. Participants in all three groups showed variable patterns of change in α leading up to treatment failure. CONCLUSIONS: We conclude that increased temporal self-similarity (α) of more variable lung function (CVpef) is associated with treatment failure, but the pattern of change in self-similarity leading up to treatment failure is variable across individuals.
引用
- Kaminsky DA, Wang LL, Bates JH, et al. Fluctuation Analysis of Peak Expiratory Flow and Its Association with Treatment Failure in Asthma. Am J Respir Crit Care Med. 2017. PMID: 27814453. doi:10.1164/rccm.201601-0076OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。